Document is current
Any future updates will be listed below
-
Authors
Liu, Yang https://orcid.org/0009-0003-6585-0145
Zhou, Fei
Ali, Heba https://orcid.org/0000-0001-5535-7638
Lathia, Justin D.
Chen, Peiwen https://orcid.org/0000-0002-8129-9328
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 NS127824, R01 NS124594, P01 CA245705, R35 NS127083)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Defense (W81XWH-21-1-0380)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 18 September 2024
First Online: 15 October 2024
Competing interests
: JDL reports being named a coinventor on pending and issued patents held by the Cleveland Clinic relating to cancer therapies, but these are not directly relevant to this review. No potential conflicts of interest are disclosed by the other authors.
